Predicting human miRNA disease association with minimize matrix nuclear norm

Ahmet Toprak1

  • 1Department of Electricity and Energy, Selcuk University, Konya, Turkey. atoprak@selcuk.edu.tr.

Scientific Reports
|December 27, 2024
PubMed

Insights

Scientists developed a novel computational method to predict microRNA (miRNA)-disease associations. This matrix decomposition approach efficiently identifies potential links, aiding in disease prevention and treatment strategies.

Area of Science:

  • Biochemistry
  • Genomics
  • Computational Biology

Background:

  • MicroRNAs (miRNAs) are non-coding RNA molecules crucial in disease development and progression.
  • miRNAs play significant roles in disease prevention, diagnosis, and treatment.
  • Experimental identification of miRNA-disease associations is costly and time-consuming.

Purpose of the Study:

  • To propose a novel computational method for predicting new miRNA-disease associations.
  • To utilize matrix decomposition and nuclear norm minimization for accurate predictions.
  • To validate the method's effectiveness, particularly for breast cancer-associated miRNAs.

Main Methods:

  • A novel computational method based on matrix decomposition was developed.
  • Nuclear norm minimization was employed to identify breast cancer-associated miRNAs.
  • The method's effectiveness was evaluated using cross-validation and compared against seven existing methods.

Main Results:

  • The proposed method demonstrated high predictive accuracy in identifying miRNA-disease relationships.
  • A case study on breast cancer further validated the computational model's reliability.
  • The results confirmed the method's superiority over several existing computational approaches.

Conclusions:

  • The novel computational method is a reliable tool for uncovering potential miRNA-disease relationships.
  • This approach offers an efficient alternative to experimental methods for miRNA-disease association discovery.
  • The findings contribute to advancing the understanding and potential therapeutic targeting of diseases through miRNAs.